Metabolic Remodelingof the NOG Pathway and Glyoxylate Cycle for High‐Yield L‐Homoserine Biosynthesis
Biotechnology and Bioengineering · 2026-10-29
DOI: 10.1002/bit.70425 ↗At a glance
Journal article in Biotechnology and Bioengineering, published online on 2026-10-29. Written by Qilan Shan and 6 co-authors. Institution: State Key Laboratory of Green Chemical Synthesis and Conversion, Zhejiang University of Technology, Hangzhou, China. 47 references. Funded by: National Key R&D Program of China.
Abstract (original language)
L‑homoserine is a valuable C4 amino acid with broad applications in agriculture, pharmaceuticals, and daily chemicals. However, existing high‑yielding strains have mainly been evaluated at laboratory scale, and their scale‑up feasibility has not yet been sufficiently verified, leaving industrial production without a direct engineering basis. In this study, a non‐auxotrophic, scalable L‑homoserine high‑producer was constructed by targeting carbon loss, rewiring the metabolic network, and maintaining cofactor balance. Specifically, the threonine branch was dynamically attenuated to reduce product degradation, while the non‑oxidative glycolysis (NOG) pathway was introduced and coupled with the glyoxylate shunt to conserve carbon and redirect flux toward the aspartate pathway, thereby increasing precursor availability. The main biosynthetic pathway and cofactor regeneration were further strengthened to accelerate L‑homoserine synthesis. Ultimately, strain HS25 achieved a titer of 126.5 g/L L‑homoserine,a yield of 0.58 g/g glucose, and a productivity of 1.77 g/L/hin 50 L fermentation. These metabolic engineering strategies are scalable and may serve as a generalizable framework for the industrial production of other aspartate‑derived amino acids and their derivatives.
Subjects
Author keywords
Authors and institutions
- State Key Laboratory of Green Chemical Synthesis and Conversion, Zhejiang University of Technology, Hangzhou, China.
- Zhejiang Key Laboratory of Bioorganic Synthesis, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.
ORCID profiles: Yang Zhou, Jianmiao Xu, Zhiqiang Liu, Yuguo Zheng
Funding
- National Key R&D Program of China
Cite
APA
Shan, Q., Zhang, J., Gong, R., Zhou, Y., Xu, J., Liu, Z., & Zheng, Y. (2026). Metabolic Remodelingof the NOG Pathway and Glyoxylate Cycle for High‐Yield L‐Homoserine Biosynthesis. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70425
Vancouver
Shan Q, Zhang J, Gong R, Zhou Y, Xu J, Liu Z, et al. Metabolic Remodelingof the NOG Pathway and Glyoxylate Cycle for High‐Yield L‐Homoserine Biosynthesis. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70425
BibTeX
@article{Shan2026,
author = {Shan, Qilan and Zhang, Jiaxue and Gong, Rui and Zhou, Yang and Xu, Jianmiao and Liu, Zhiqiang and Zheng, Yuguo},
title = {Metabolic Remodelingof the NOG Pathway and Glyoxylate Cycle for High‐Yield L‐Homoserine Biosynthesis},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70425}
}
EUVIMED